tolvaptan has been researched along with Liver Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, E; Hoshino, J; Ikuma, D; Mizuno, H; Sawa, N; Sekine, A; Suwabe, T; Ubara, Y; Yamanouchi, M | 1 |
| Abe, H; Arai, T; Atsukawa, M; Chuma, M; Fukunishi, S; Hattori, N; Hiraoka, A; Iio, E; Ikegami, T; Itokawa, N; Iwakiri, K; Iwasa, M; Kato, K; Kondo, C; Kumada, T; Michitaka, K; Nakagawa-Iwashita, A; Nozaki, A; Okubo, H; Okubo, T; Senoh, T; Tada, T; Takaguchi, K; Takei, Y; Tanaka, Y; Tani, J; Toyoda, H; Tsubota, A; Tsutsui, A; Uojima, H; Watanabe, T; Yokohama, K; Yoshida, Y | 1 |
| Fukuta, Y; Hirano, T; Kurosaki, M; Okada, M; Sakaida, I; Terai, S | 1 |
| Ando, H; Fukada, H; Kanazawa, R; Kokubu, S; Miyazaki, A; Nakadera, E; Okubo, H; Sagawa, E; Sorin, Y | 1 |
| Kitajima, M; Miura, S; Takenaka, T | 1 |
5 other study(ies) available for tolvaptan and Liver Diseases
| Article | Year |
|---|---|
Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use.
Topics: Antidiuretic Hormone Receptor Antagonists; Case-Control Studies; Cysts; Female; Humans; Kidney; Liver; Liver Diseases; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Prognosis; Retrospective Studies; Tolvaptan | 2022 |
Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema.
Topics: Adult; Aged; Aged, 80 and over; Diuretics; Drug Therapy, Combination; Edema; Female; Furosemide; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Prognosis; Retrospective Studies; ROC Curve; Spironolactone; Survival Rate; Time Factors; Tolvaptan | 2020 |
Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study).
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Blood Urea Nitrogen; Edema; Female; Humans; Japan; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Product Surveillance, Postmarketing; Prospective Studies; Tolvaptan; Treatment Outcome | 2020 |
Plasma concentration and efficacy of tolvaptan in cirrhotic patients with refractory ascites.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Edema; Female; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Serum Albumin; Tolvaptan; Treatment Outcome | 2019 |
The management of polycystic liver disease by tolvaptan.
Topics: Abdomen; Adult; Antidiuretic Hormone Receptor Antagonists; Cysts; Female; Humans; Kidney; Liver; Liver Diseases; Tolvaptan; Tomography, X-Ray | 2020 |